×

Celgene CEO: Precision medicine targeting metabolic drivers of disease

8:15 AM ET Thu, 3 Aug 2017

Mark Alles, Celgene CEO, talks about gaining FDA approval for a drug that targets a lethal form of leukemia and discusses the importance of getting patients access to precision medicines.